Work

mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer

Year: 2018

Type: article

Source: Oncogene

DOI: 10.1038/s41388-018-0479-6

Authors: Shun-Qing Liang, Elias D. Bührer, Sabina Berezowska, Thomas M. Marti, Duo Xu, Laurène Froment, Haitang Yang, Sean R. R. Hall, Erik Vassella, Zhang Yang, Gregor J. Kocher, Michael A. Amrein, Carsten Riether, Adrian F. Ochsenbein, Ralph A. Schmid, Ren-Wang Peng

Institutions: University of Bern, University Hospital of Bern

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2889171823

FWCI: 2.029

Cites: 47

Cited by: 56

Related to: 10